These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33495841)

  • 1. Allisartan isoproxil attenuates oxidative stress and inflammation through the SIRT1/Nrf2/NF‑κB signalling pathway in diabetic cardiomyopathy rats.
    Jin Q; Zhu Q; Wang K; Chen M; Li X
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salusin-β contributes to oxidative stress and inflammation in diabetic cardiomyopathy.
    Zhao MX; Zhou B; Ling L; Xiong XQ; Zhang F; Chen Q; Li YH; Kang YM; Zhu GQ
    Cell Death Dis; 2017 Mar; 8(3):e2690. PubMed ID: 28333148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats.
    Luo J; Yan D; Li S; Liu S; Zeng F; Cheung CW; Liu H; Irwin MG; Huang H; Xia Z
    J Cell Mol Med; 2020 Jan; 24(2):1760-1773. PubMed ID: 31856386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A SIRT1 agonist reduces cognitive decline in type 2 diabetic rats through antioxidative and anti‑inflammatory mechanisms.
    Wang F; Shang Y; Zhang R; Gao X; Zeng Q
    Mol Med Rep; 2019 Feb; 19(2):1040-1048. PubMed ID: 30483738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection by dimethyl fumarate against diabetic cardiomyopathy in type 1 diabetic mice likely via activation of nuclear factor erythroid-2 related factor 2.
    Hu X; Rajesh M; Zhang J; Zhou S; Wang S; Sun J; Tan Y; Zheng Y; Cai L
    Toxicol Lett; 2018 May; 287():131-141. PubMed ID: 29408448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double blind, placebo-controlled, multicenter phase II trial of Allisartan Isoproxil in essential hypertensive population at low-medium risk.
    Li Y; Li XH; Huang ZJ; Yang GP; Zhang GG; Zhao SP; Guo Y; Lu SJ; Ma JL; Meng FB; Chen P; Yuan H
    PLoS One; 2015; 10(2):e0117560. PubMed ID: 25693004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaempferol attenuates hyperglycemia-induced cardiac injuries by inhibiting inflammatory responses and oxidative stress.
    Chen X; Qian J; Wang L; Li J; Zhao Y; Han J; Khan Z; Chen X; Wang J; Liang G
    Endocrine; 2018 Apr; 60(1):83-94. PubMed ID: 29392616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress.
    You S; Qian J; Sun C; Zhang H; Ye S; Chen T; Xu Z; Wang J; Huang W; Liang G
    J Cell Mol Med; 2018 Mar; 22(3):1931-1943. PubMed ID: 29327811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piceatannol alleviates inflammation and oxidative stress via modulation of the Nrf2/HO-1 and NF-κB pathways in diabetic cardiomyopathy.
    Li H; Shi Y; Wang X; Li P; Zhang S; Wu T; Yan Y; Zhan Y; Ren Y; Rong X; Xia T; Chu M; Wu R
    Chem Biol Interact; 2019 Sep; 310():108754. PubMed ID: 31323227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway.
    Liu X; Guo B; Zhang W; Ma B; Li Y
    J Biochem; 2021 Oct; 170(3):349-362. PubMed ID: 33837411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting I
    Liao HH; Zhu JX; Feng H; Ni J; Zhang N; Chen S; Liu HJ; Yang Z; Deng W; Tang QZ
    Oxid Med Cell Longev; 2017; 2017():8370593. PubMed ID: 29147465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guan Xin Dan Shen formulation protects
    Zhang B; Zhang CY; Zhang XL; Sun GB; Sun XB
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses.
    Li L; Luo W; Qian Y; Zhu W; Qian J; Li J; Jin Y; Xu X; Liang G
    Phytomedicine; 2019 Jun; 59():152774. PubMed ID: 31009852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bicyclol Alleviates Streptozotocin-induced Diabetic Cardiomyopathy By Inhibiting Chronic Inflammation And Oxidative Stress.
    Zhang L; Hu C; Jin B; Bai B; Liao J; Jin L; Wang M; Zhu W; Wu X; Zheng L; Xu X; Jiang Y; Wang Y; He Y
    Cardiovasc Drugs Ther; 2024 Jun; 38(3):555-568. PubMed ID: 36662448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mangiferin suppressed advanced glycation end products (AGEs) through NF-κB deactivation and displayed anti-inflammatory effects in streptozotocin and high fat diet-diabetic cardiomyopathy rats.
    Hou J; Zheng D; Fung G; Deng H; Chen L; Liang J; Jiang Y; Hu Y
    Can J Physiol Pharmacol; 2016 Mar; 94(3):332-40. PubMed ID: 26751764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LCZ696 Protects against Diabetic Cardiomyopathy-Induced Myocardial Inflammation, ER Stress, and Apoptosis through Inhibiting AGEs/NF-κB and PERK/CHOP Signaling Pathways.
    Belali OM; Ahmed MM; Mohany M; Belali TM; Alotaibi MM; Al-Hoshani A; Al-Rejaie SS
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIRT6‑specific inhibitor OSS‑128167 exacerbates diabetic cardiomyopathy by aggravating inflammation and oxidative stress.
    Huang Y; Zhang J; Xu D; Peng Y; Jin Y; Zhang L
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced glycation end-products impair Na⁺/K⁺-ATPase activity in diabetic cardiomyopathy: role of the adenosine monophosphate-activated protein kinase/sirtuin 1 pathway.
    Yuan Q; Zhou QY; Liu D; Yu L; Zhan L; Li XJ; Peng HY; Zhang XL; Yuan XC
    Clin Exp Pharmacol Physiol; 2014 Feb; 41(2):127-33. PubMed ID: 24341361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats.
    Yu W; Wu J; Cai F; Xiang J; Zha W; Fan D; Guo S; Ming Z; Liu C
    PLoS One; 2012; 7(12):e52013. PubMed ID: 23251674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galangin attenuates diabetic cardiomyopathy through modulating oxidative stress, inflammation and apoptosis in rats.
    Abukhalil MH; Althunibat OY; Aladaileh SH; Al-Amarat W; Obeidat HM; Al-Khawalde AAA; Hussein OE; Alfwuaires MA; Algefare AI; Alanazi KM; Al-Swailmi FK; Arab HH; Mahmoud AM
    Biomed Pharmacother; 2021 Jun; 138():111410. PubMed ID: 33752930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.